Medicines Not Reimbursed Through National Prices and Directly Commissioned by Nhs England V14 Changes to Version 13

Medicines Not Reimbursed Through National Prices and Directly Commissioned by Nhs England V14 Changes to Version 13

MEDICINES NOT REIMBURSED THROUGH NATIONAL PRICES AND DIRECTLY COMMISSIONED BY NHS ENGLAND V14 CHANGES TO VERSION 13 PUBLISHED APRIL 2019 Changes to v13 Lines removed SUITABLE SPECIALIST FOR CENTRE SUITABLE FOR SHARED ONLY SHARED CARE CARE PRIOR (includng WITH PRIMARY BETWEEN STOPPING MONITORING/ AUDIT APPROVAL outreach CARE (IF DRUG NAME INDICATION COMMISSIONER PBR CATEGORY TA/POLICY STARTING CRITERIA SPECIALIST COMMENT CRITERIA REQUIREMENTS PROFORMA when SUPPORTED AND REQUIRED delivered as BY LOCAL SECONDARY part of a PRESCRIBING CARE VIA provider COMMITTEE) NETWORK network) MODEL PAEDIATRIC INDICATIONS (IN LINE WITH NHS ENGLAND AS PER ADULT TA'S (TA195, TA373, ABATACEPT NHS ENGLAND CYTOKINE MODULATORS NICE NICE NICE √ MEDICINES FOR CHILDREN TA375) POLICY) Now covered by comment 8 PAEDIATRIC INDICATIONS (IN AS PER TA455 OR ADULT TA'S (TA130 LINE WITH NHS ENGLAND (replaced by TA375), TA143 (repalced by ADALIMUMAB NHS ENGLAND CYTOKINE MODULATORS NICE NICE NICE AUDIT √ √ MEDICINES FOR CHILDREN TA383), TA146, TA187, TA199, TA329, POLICY) TA392, TA460) Now covered by comment 8 ALBUTREPENONACOG ALFA HAEMOPHILIA B PRODUCTS ON CMU Blood factor products simplified NHS ENGLAND BLOOD-RELATED PRODUCTS SSC 1652 SSC 1652 SSC 1652 √ FRAMEWORK to blood factor product VIII etc PAEDIATRIC INDICATIONS (IN LINE WITH NHS ENGLAND AS PER IFR AS PER IFR ANAKINRA NHS ENGLAND CYTOKINE MODULATORS NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ MEDICINES FOR CHILDREN APPROVAL APPROVAL POLICY) Now covered by comment 8 AS PER BCSH GUIDELINES ANTIHAEMOPHILIC FACTOR/VON BCSH PRODUCTS ON CMU Blood factor products simplified FOR SPECIALISED NHS ENGLAND BLOOD-RELATED PRODUCTS BCSH GUIDELINES BCSH GUIDELINES √ WILLEBRAND FACTOR COMPLEX GUIDELINES FRAMEWORK to blood factor product VIII etc INDICATIONS PAEDIATRIC INDICATIONS (IN LINE WITH NHS ENGLAND AS PER IFR AS PER IFR APREMILAST NHS ENGLAND CYTOKINE MODULATORS NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ MEDICINES FOR CHILDREN APPROVAL APPROVAL POLICY) Now covered by comment 8 INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products ARAGAM AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) AS PER IFR AS PER IFR AVORALSTAT HEREDITARY ANGIOEDEMA NHS ENGLAND ALLERGIC EMERGENCIES NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ Never licensed APPROVAL APPROVAL PAEDIATRIC INDICATIONS AS PER IFR AS PER IFR BARICITINIB (WHERE ADULT TA NHS ENGLAND IMMUNOMODULATING DRUGS NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ APPROVAL APPROVAL AVAILABLE) Now covered by comment 8 RESPIRATORY DISTRESS TRUST BERACTANT NHS ENGLAND PULMONARY SURFACTANTS AGREED TRUST GUIDELINES TRUST GUIDELINES √ Moving into tariff SYNDROME GUIDELINES PAEDIATRIC INDICATIONS AS PER IFR AS PER IFR BRODALIMUMAB (WHERE ADULT TA NHS ENGLAND IMMUNOMODULATING DRUGS NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ Now covered by comment 8 APPROVAL APPROVAL AVAILABLE) CONGENITAL FACTOR XIII A- AS PER IFR AS PER IFR Blood factor products simplified CATRIDECACOG NHS ENGLAND BLOOD-RELATED PRODUCTS NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ SUBUNIT DEFICIENCY APPROVAL APPROVAL to blood factor product VIII etc PAEDIATRIC INDICATIONS (IN LINE WITH NHS ENGLAND AS PER IFR AS PER IFR CERTOLIZUMAB PEGOL NHS ENGLAND CYTOKINE MODULATORS NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ Now covered by comment 8 MEDICINES FOR CHILDREN APPROVAL APPROVAL POLICY) PAEDIATRIC INDICATIONS DRUGS AFFECTING THE IMMUNE AS PER IFR AS PER IFR COBITOLIMOD (WHERE ADULT TA NHS ENGLAND NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ Now covered by comment 8 RESPONSE APPROVAL APPROVAL AVAILABLE) AS PER IFR AS PER IFR Changed to NRC following loss of DACLIZUMAB MULTIPLE SCLEROSIS NHS ENGLAND IMMUNOMODULATING DRUGS NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ APPROVAL APPROVAL licence VIRAL HEPATITIS (B&C) & AS PER RUN RATE AS PER RUN DASABUVIR HEPATITIS C NHS ENGLAND TA 365 HEPATITIS C MDS √ √ Corrected to reflect TA status RESPIRATORY SYNCYTIAL VIRUS CARD RATE CARD PAEDIATRIC INDICATIONS (IN LINE WITH NHS ENGLAND AS PER TA455 OR ADULT TA'S (TA103, ETANERCEPT NHS ENGLAND CYTOKINE MODULATORS NICE NICE NICE AUDIT √ √ Now covered by comment 8 MEDICINES FOR CHILDREN TA130, TA143, TA199) POLICY) PAEDIATRIC INDICATIONS (IN LINE WITH NHS ENGLAND DRUGS AFFECTING THE IMMUNE AS PER IFR AS PER IFR ETROLIZUMAB NHS ENGLAND NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ Now covered by comment 8 MEDICINES FOR CHILDREN RESPONSE APPROVAL APPROVAL POLICY) HIGHLY HIGHLY FILGRASTIM BARTH SYNDROME NHS ENGLAND DRUGS USED IN NEUTROPENIA HIGHLY SPECIALISED CRITERIA ONLY SPECIALISED SPECIALISED √ Moving into tariff CRITERIA ONLY CRITERIA ONLY NUMBER OF PATIENTS TREATED PROPORTION GIVEN TRUST FOR SPC INDICATIONS Moving into tariff but added to FILGRASTIM NEUTROPENIA NHS ENGLAND DRUGS USED IN NEUTROPENIA SPC TRUST GUIDELINES √ GUIDELINES WITHIN POLICY supportive drug list PRODUCT WITH LOWEST ACQUISITION COST TO BE USED PAEDIATRIC INDICATIONS (IN LINE WITH NHS ENGLAND DRUGS AFFECTING THE IMMUNE AS PER IFR AS PER IFR FILGOTINIB NHS ENGLAND NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ Now covered by comment 8 MEDICINES FOR CHILDREN RESPONSE APPROVAL APPROVAL POLICY) VIRAL HEPATITIS (B&C) & AS PER IFR AS PER IFR FILIBUVIR HEPATITIS C NHS ENGLAND NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ Never licensed RESPIRATORY SYNCYTIAL VIRUS APPROVAL APPROVAL INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products FLEBOGAMMA AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products FLEBOGAMMADIF AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products GAMMAGARD AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products GAMMANORM AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products GAMMAPLEX AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products GAMUNEX AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) AS PER IFR AS PER IFR Blood factor products simplified GLYCOPEGYLATED FACTOR IX HAEMOPHILIA A NHS ENGLAND BLOOD-RELATED PRODUCTS NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ APPROVAL APPROVAL to blood factor product VIII etc GOLIMUMAB PAEDIATRIC INDICATIONS NHS ENGLAND CYTOKINE MODULATORS AS PER ADULTS TA'S (TA220, TA233) NICE NICE NICE AUDIT √ Now covered by comment 8 INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products HIZENTRA AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) INTRAVENOUS/SUBCUTANEOUS AS PER IFR AS PER IFR Immunoglobulin products HYQVIA AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ APPROVAL APPROVAL simplified to IV or sc IMMUNOGLOBULINS PAEDIATRIC INDICATIONS (IN AS PER ADULT TA'S (TA130 (replaced LINE WITH NHS ENGLAND by TA375), TA134, TA140, TA143 INFLIXIMAB NHS ENGLAND CYTOKINE MODULATORS NICE NICE NICE AUDIT √ √ Now covered by comment 8 MEDICINES FOR CHILDREN (repalced by TA383), TA163, TA187, POLICY) TA199, TA329) INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products INTRATECT AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) INTRAVENOUS/SUBCUTANEOUS CLINICAL GUIDELINES FOR NATIONAL NATIONAL Immunoglobulin products KIOVIG AS PER NATIONAL DMP NHS ENGLAND HUMAN NORMAL IMMUNOGLOBULIN USE, SECOND QUALITY DASHBOARD √ GUIDELINES GUIDELINES simplified to IV or sc IMMUNOGLOBULINS EDITION UPDATE (JULY 2011) NUMBER OF PATIENTS TREATED PROPORTION GIVEN TRUST FOR SPC INDICATIONS LENOGRASTIM NEUTROPENIA NHS ENGLAND DRUGS USED IN NEUTROPENIA SPC TRUST GUIDELINES √ Moving into tariff GUIDELINES WITHIN POLICY PRODUCT WITH LOWEST ACQUISITION COST TO BE USED HIGHLY HIGHLY Moving into tariff but added to LENOGRASTIM BARTH SYNDROME NHS ENGLAND DRUGS USED IN NEUTROPENIA HIGHLY SPECIALISED CRITERIA ONLY SPECIALISED SPECIALISED √ supportive drug list CRITERIA ONLY CRITERIA ONLY AS PER IFR AS PER IFR LIPEGFILGRASTIM NEUTROPENIA NHS ENGLAND DRUGS USED IN NEUTROPENIA NOT ROUTINELY COMMISSIONED AS PER IFR APPROVAL √ Moving into tariff APPROVAL APPROVAL

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    10 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us